Severe Occupational Asthma: Insights From a Multicenter European Cohort

J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2309-2318.e4. doi: 10.1016/j.jaip.2019.03.017. Epub 2019 Mar 23.

Abstract

Background: Although sensitizer-induced occupational asthma (OA) accounts for an appreciable fraction of adult asthma, the severity of OA has received little attention.

Objective: The aim of this study was to characterize the burden and determinants of severe OA in a large multicenter cohort of subjects with OA.

Methods: This retrospective study included 997 subjects with OA ascertained by a positive specific inhalation challenge completed in 20 tertiary centers in 11 European countries during the period 2006 to 2015. Severe asthma was defined by a high level of treatment and any 1 of the following criteria: (1) daily need for a reliever medication, (2) 2 or more severe exacerbations in the previous year, or (3) airflow obstruction.

Results: Overall, 162 (16.2%; 95% CI, 14.0%-18.7%) subjects were classified as having severe OA. Multivariable logistic regression analysis revealed that severe OA was associated with persistent (vs reduced) exposure to the causal agent at work (odds ratio [OR], 2.78; 95% CI, 1.50-5.60); a longer duration of the disease (OR, 1.04; 95% CI, 1.00-1.07); a low level of education (OR, 2.69; 95% CI, 1.73-4.18); childhood asthma (OR, 2.92; 95% CI, 1.13-7.36); and sputum production (OR, 2.86; 95% CI, 1.87-4.38). In subjects removed from exposure, severe OA was associated only with sputum production (OR, 3.68; 95% CI, 1.87-7.40); a low education level (OR, 3.41; 95% CI, 1.72-6.80); and obesity (OR, 1.98; 95% CI, 0.97-3.97).

Conclusions: This study indicates that a substantial proportion of subjects with OA experience severe asthma and identifies potentially modifiable risk factors for severe OA that should be targeted to reduce the adverse impacts of the disease.

Keywords: Airflow obstruction; Asthma control; Asthma exacerbations; Occupational asthma; Severe asthma.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-2 Receptor Agonists / therapeutic use
  • Adult
  • Asthma, Occupational / drug therapy
  • Asthma, Occupational / epidemiology*
  • Asthma, Occupational / physiopathology
  • Europe
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Middle Aged
  • Occupational Exposure / adverse effects
  • Odds Ratio
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index

Substances

  • Adrenergic beta-2 Receptor Agonists